hsa_circ_103809 was highly expressed in breast cancer tissues and cells, and may play an oncogene role in the development of breast cancer, and is expected to become a new target for breast cancer therapy.
circ_103809 promotes breast cancer progression by regulating the PI3K/AKT signaling pathway.